UNCODE.initHeader(); Vancouver, B.C., January 3, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce a non-brokered private placement of up to 3,571,000 units at a price of CAD$2.80 per unit.

Each unit will consist of one common share and one transferable common share purchase warrant.  Each warrant will entitle the holder to acquire one additional common share for a period of 24 months following the closing of the private placement at a price of CAD$4.00 per warrant share.

In the event that, after the date that is six months and one day following the closing of the offering, the closing volume-weighted average price of the common shares on the Canadian Securities Exchange, or such other exchange on which the common shares may primarily trade, is greater than or equal to CAD$5.50 for a period of ten consecutive trading days, the Company may, at its sole option, accelerate the expiry date of the warrants by giving notice to the holders thereof, and in such case, the warrants will expire on the 30th day after the date on which such notice is given by the Company.

The offering was priced in the context of the market based on a price reservation made by the Company with the Canadian Securities Exchange.  The private placement is subject to the approval of the CSE and the securities will be subject to a four-month hold period under securities laws.  The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.  MYM has two production projects in Québec that when completed will have over 1.5 million square feet of production space.  MYM is also a partner in a 1.2 million square-foot production project (the Northern Rivers Project) in New South Wales, Australia.  Australia is an exciting new market that has recently legalized medicinal cannabis.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).


Rob Gietl, CEO
MYM Nutraceuticals Inc.

Investor Relations
Terry Brown